Menicon Co., Ltd. owns 2 brands in our database. Browse the complete portfolio of Menicon Co., Ltd. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Nagoya, Aichi, Japan
Brand Portfolio
2 brands
Stock
TSE: 7780
Showing Healthcare & Pharmaceuticals brands
2 of 2 total brands
Healthcare PharmaceuticalsOwned by Menicon Co., Ltd.
Contact lens brand owned by Menicon, headquartered in Singapore, producing biocompatible daily disposable and monthly silicone hydrogel lenses for Asia-Pacific and global markets.
Owned by Menicon Co., Ltd.
Japan's first and largest contact lens manufacturer, founded in 1951 in Nagoya. Known for rigid gas permeable lenses, orthokeratology, and expanding daily disposable silicone hydrogel products.
What does Menicon own?
Menicon owns a portfolio of contact lens brands and manufacturing subsidiaries. The company produces rigid gas permeable lenses under the Menicon brand, daily disposable lenses through ClearLab in Singapore, specialized rigid and soft lenses through NKL in the Netherlands, and specialized contact lenses through Menicon UK. The company also manufactures lens care solutions and is developing intraocular lenses.
Is Menicon publicly traded?
Yes, Menicon Co., Ltd. trades on the Tokyo Stock Exchange Prime Market under ticker 7780. The company is classified in the Precision Instruments industry category and has a fiscal year ending in March. Menicon was founded in February 1951 and incorporated in July 1957.
Who founded Menicon?
Menicon was founded in February 1951 by Kyoichi Tanaka, who developed Japan's first practical corneal contact lens. Tanaka was working at an optical shop when he learned about contact lenses from the wife of a US Army officer. After extensive research, he succeeded in creating a practical lens. He established the Nippon Contact Lens Research Institute in 1952 with his brother and Dr. Mizutani.
What is Menicon's main business?
Menicon manufactures and sells contact lenses and lens care products. The company is the only manufacturer in the world dedicated to all areas of contact lens-related business, including material development, lens design, manufacturing of contact lenses, and production of care solutions. Its products include rigid gas permeable lenses, daily disposables, specialty lenses, and lens care solutions.
What were Menicon's FY2026 financial results?
Menicon reported FY2026 (fiscal year ended March 2026) revenue of 125.6 billion yen, up 3.4% from FY2025. Net income was 5.92 billion yen, up 5.2% from the prior year, with a profit margin of 4.7%. Analysts forecast revenue of approximately 132.4 billion yen for FY2027, representing 3.6% growth.
What is ClearLab?
ClearLab is Menicon's Singapore-based subsidiary that manufactures daily disposable contact lenses. The facility at International Business Park opened in 2011 with an investment of $97 million and was Menicon's first production site outside Japan for daily disposables. ClearLab also houses Menicon's first R&D center in Asia outside Japan.
Where does Menicon manufacture its products?
Menicon manufactures contact lenses in Japan, Singapore, the Netherlands, the United Kingdom, and Malaysia. The Japan facilities produce RGP lenses and other products. ClearLab in Singapore produces daily disposables. NKL in the Netherlands manufactures rigid and soft made-to-order lenses. Menicon UK produces specialized lenses. The new Malaysia smart factory, launched in February 2026, produces silicone hydrogel daily disposables.
No competing brands found in the same categories. This could be because Menicon Co., Ltd.operates in unique market segments or we're still building our competitor database.
Menicon Co., Ltd. maintains a diverse portfolio of 2 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Menicon Co., Ltd.provides valuable insights into market dynamics, product relationships, and corporate strategy.